ArticleTranslational vision science & technology2025
Performance of General-Purpose Vision Language Models and Ophthalmology Foundation Models in Glaucoma Detection and Function Prediction.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Image-Quality-Aware Multimodal Artificial Intelligence for Automated Structured OCT Report Generation in Glaucoma Evaluation.Ophthalmology science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Purpose: To evaluate the performance of vision-language models (VLMs), in glaucoma detection and visual field (VF) mean deviation (MD) prediction tasks using optical coherence tomography (OCT) images. Methods: A total of 27,610 SPECTRALIS OCT images from 1025 participants (1690 eyes), collected between 2008 and 2021 as part of the Diagnostic Innovations in Glaucoma Study (DIGS) and the African Descent and Glaucoma Evaluation Study (ADAGES), were included. Vision components of LLaVA and PaliGemma, as well as RETFound and ResNet-50 models, were fine-tuned for glaucoma classification and VF MD prediction. Models were trained using OCT circle scans centered on the optic nerve head. Three training configurations were compared. Performance was evaluated using area under the receiver operating characteristic curve (AUC), mean absolute error (MAE), and related metrics. Results: The LLaVA model, when both vision encoder and multi-layer projector were fine-tuned, achieved the best performance with an AUC of 0.92 (95% confidence interval [CI], 0.86-0.95) for glaucoma classification and an MAE of 1.79 dB (95% CI, 1.55-2.00) for VF MD prediction. RETFound and PaliGemma also performed well, with AUCs of 0.91 and 0.90 and MAEs of 1.87 dB and 1.84 dB, respectively. Models with frozen vision encoders showed reduced accuracy. Stratified analysis showed better glaucoma classification in older individuals and moderate-to-advanced cases. VF MD prediction was more accurate in younger individuals, with higher errors in advanced glaucoma. Conclusions: Fine-tuned VLMs demonstrated high performance in glaucoma detection and VF MD prediction, matching or exceeding specialized foundation models and traditional convolutional neural network (CNN)-based methods. Translational Relevance: This study highlights the potential of general-purpose AI models to be adapted for glaucoma care, enabling scalable decision support from OCT imaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.